CENTOCOR's MYOSCINT RECOMMENDED FOR APPROVAL AS FIRST MONOCLONAL IMAGING AGENT FOR USE IN DETECTION OF TISSUE DEATH FOLLOWING MYOCARDIAL INFARCTION